(NYSE: ALB) Albemarle's forecast annual revenue growth rate of 4.23% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 4.64%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.43%.
Albemarle's revenue in 2026 is $5,907,904,000.On average, 24 Wall Street analysts forecast ALB's revenue for 2026 to be $727,737,186,519, with the lowest ALB revenue forecast at $670,386,728,817, and the highest ALB revenue forecast at $792,403,957,755. On average, 22 Wall Street analysts forecast ALB's revenue for 2027 to be $752,046,228,261, with the lowest ALB revenue forecast at $597,695,613,705, and the highest ALB revenue forecast at $898,608,509,055.
In 2028, ALB is forecast to generate $792,875,977,983 in revenue, with the lowest revenue forecast at $581,764,931,010 and the highest revenue forecast at $985,224,220,893.